| 产品名称 | Peptides EP11463_1 | VP1 372-380 (HLA-B*07:02) |
|---|---|
| 目录号 | EP11463_1 |
| 别名 | VP1 372-380 (HLA-B*07:02) |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| EP11463_1 | 1 mg; 5 mg | 咨询 | 咨询 |
Peptides EP11463_1 | VP1 372-380 (HLA-B*07:02)
品名：VP1 372-380 (HLA-B*07:02)
货号：EP11463_1
规格：1 mg; 5 mg
品牌：Peptides.de
产品描述
This peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assaysThis peptide is the capsid derived immunodominant adeno-associated virus 2 (AAV2), CD8 T cell epitope. Liver toxicity observed in a clinical trial of AAV2 delivered systemically to patients with hemophilia was ascribed to killing of vector-transduced hepatocytes by capsid-specific T-cells. VPQYGYLTL is a linear peptidic epitope (epitope ID70458) studied as part of Capsid protein VP1 from Adeno-associated dependoparvovirus A. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
| Protein | Capsid protein |
| Species | Adeno-associated virus |
| Application | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication | Infectious disease |
